PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells
- 10 September 2009
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 220 (1), 87-96
- https://doi.org/10.1002/path.2620
Abstract
Telomerase is an RNA‐dependent DNA polymerase that synthesizes telomeric DNA. Its activity is not detectable in most somatic cells but it is reactivated during tumorigenesis. In most cancers, the combination of hTERT hypermethylation and hypomethylation of a short promoter region is permissive for low‐level hTERT transcription. Activated and malignant lymphocytes express high telomerase activity, through a mechanism that seems methylation‐independent. The aim of this study was to determine which mechanism is involved in the enhanced expression of hTERT in lymphoid cells. Our data confirm that in B cells, some T cell lymphomas and non‐neoplastic lymph nodes, the hTERT promoter is unmethylated. Binding sites for the B cell‐specific transcription factor PAX5 were identified downstream of the ATG translational start site through EMSA and ChIP experiments. ChIP assays indicated that the transcriptional activation of hTERT by PAX5 does not involve repression of CTCF binding. In a B cell lymphoma cell line, siRNA‐induced knockdown of PAX5 expression repressed hTERT transcription. Moreover, ectopic expression of PAX5 in a telomerase‐negative normal fibroblast cell line was found to be sufficient to activate hTERT expression. These data show that activation of hTERT in telomerase‐positive B cells is due to a methylation‐independent mechanism in which PAX5 plays an important role. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 47 references indexed in Scilit:
- Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factorsNucleic Acids Research, 2007
- B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signalingJCI Insight, 2007
- Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysisJournal of Clinical Pathology, 2007
- Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT geneNucleic Acids Research, 2007
- Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivationHuman Molecular Genetics, 2005
- Pax5 inducesV-to-DJrearrangements and locus contraction of theimmunoglobulin heavy-chaingeneGenes & Development, 2004
- Paired-Box genes are frequently expressed in cancer and often required for cancer cell survivalOncogene, 2003
- Control of Pre-BCR Signaling by Pax5-Dependent Activation of the BLNK GeneImmunity, 2002
- Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activityInternational Journal of Cancer, 2002
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997